Esperion Therapeutics, 4% 15nov2025, USD (Conv.) (FIGI BBG00Y60CH98)
国内債券, 転換社債, トレース適格, Senior Subordinated Unsecured
国内債券, 転換社債, トレース適格, Senior Subordinated Unsecured
|
Esperion Therapeutics, Inc., a lipid management company, focuses on developing and commercializing oral therapies for the treatment of patients with elevated low-density lipoprotein cholesterol (LDL-C).
|
|
|
|
|
|
|
|
|
最も包括的なデータベースを探索
1 000 000
債券
80 234
株
175 910
ETF&投資信託
70 000
インデックス
最も効率的な方法でポートフォリオを追跡
| 2026 | |
| 2025 | |
| 2024 | |
| 2023 | |
| 2022 | |
| 2021 | |
| 2020 | |
| 2019 | |
| 2018 | |
| 2017 | |
| 2016 | |
| 2015 | |
| 2014 | |